DCTD

Deoxycytidylate deaminase · P32321 · DCTD on Sugi Atlas →

0 patent compounds predicted against DCTD, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DCTD by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment PHASE4RECRUITING
Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE3COMPLETED
S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. PHASE3COMPLETED
Acelarin First Line Randomised Pancreatic Study PHASE2/PHASE3SUSPENDED
Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene PHASE2COMPLETED
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer PHASE2COMPLETED
A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) PHASE2COMPLETED
Antifolate Effectiveness in Arthritis PHASE2COMPLETED
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine PHASE1/PHASE2ACTIVE_NOT_RECRUITING
A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer PHASE2COMPLETED
Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV PHASE1/PHASE2COMPLETED
S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer PHASE2COMPLETED
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery PHASE2COMPLETED
Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer PHASE2UNKNOWN
FdCyd and THU for Advanced Solid Tumors PHASE1COMPLETED
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE1UNKNOWN
5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer PHASE1COMPLETED
Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors PHASE1COMPLETED
PRO#0118: Decitabine Plus Mini Flu-Bu PHASE1COMPLETED
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors PHASE1RECRUITING
A RETROspective Study of Patients With TK2d nanCOMPLETED
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. nanCOMPLETED
Observational Study Evaluating the Prevalence of Enzyme Deficiency in Pulmonology Clinics (ADA) nanUNKNOWN
Prevalence of Adenosine Deaminase (ADA) Enzyme Deficiency Disease in Adult Patients With Pulmonary Alveolar Proteinosis nanUNKNOWN
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer nanUNKNOWN
Evaluation of Adenosine Deaminase (ADA) Enzyme Deficiency in Patients With Lymphopenia and/or Elevated Immunoglobulin E nanUNKNOWN
Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer nanUNKNOWN
Registry Study of Revcovi Treatment in Patients With ADA-SCID nanCOMPLETED
The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line nanUNKNOWN
Investigation of ADA Enzyme Deficiency nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a DCTD binder may also engage these)

ProteinNameSimilarity
Q5M9G0 1.000 Q5M9G0 →
Q5RC69 1.000 Q5RC69 →
Q8K2D6 1.000 Q8K2D6 →
Q9VWA2 0.987 Q9VWA2 →
P33968 0.985 P33968 →
P30648 0.983 P30648 →
Q9SU87 0.976 Q9SU87 →
P06773 0.976 P06773 →
P00814 0.975 P00814 →
P32393 0.975 P32393 →
P16006 0.973 P16006 →
O59834 0.973 O59834 →
Q8JFW4 0.973 Q8JFW4 →
Q5R5P3 0.972 Q5R5P3 →
O43012 0.972 O43012 →
A2BUP5 0.971 A2BUP5 →
A3PAY5 0.970 A3PAY5 →
O34598 0.970 O34598 →
Q31CR8 0.969 Q31CR8 →
B0JVA7 0.969 B0JVA7 →
Q5RF63 0.969 Q5RF63 →
Q93K96 0.968 Q93K96 →
A2RUV5 0.968 A2RUV5 →
P78594 0.968 P78594 →
O88428 0.968 O88428 →
P11832 0.968 P11832 →
P11035 0.968 P11035 →
P11605 0.968 P11605 →
Q9FR44 0.968 Q9FR44 →
A0A1D6NER6 0.968 A0A1D6NER6 →